Savara Inc. Announces New Inducement Awards for Employees Under 2021 Equity Incentive Plan
Savara Inc., a clinical stage biopharmaceutical company specializing in rare respiratory diseases, has announced the issuance of inducement awards to two newly hired employees. As of July 15, 2025, these awards include options to purchase a total of 20,000 shares of Savara's common stock, with an exercise price of $2.29 per share, and restricted stock units (RSUs) for an additional 20,000 shares. These awards are part of the Savara Inc. 2021 Inducement Equity Incentive Plan and are granted under NASDAQ Listing Rules. The stock options have a term of 10 years and vest quarterly over four years, while the RSUs will fully vest on the two-year anniversary of employment, contingent upon the employees' continued tenure with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250718610099) on July 18, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。